Search results
Results from the WOW.Com Content Network
Which autism spectrum diagnoses can be made and which criteria are used depends on the local healthcare system's regulations. According to the DSM-5-TR (2022), in order to receive a diagnosis of autism spectrum disorder, one must present with "persistent deficits in social communication and social interaction" and "restricted, repetitive ...
Practicing some relaxing bedtime rituals, like having a cup of tea or taking a bath, and keeping electronics out of the bedroom can help quiet your mind so you can get to sleep. 8. Seek ...
The Modified Checklist for Autism in Toddlers (M-CHAT) is a psychological questionnaire that evaluates risk for autism spectrum disorder in children ages 16–30 months. The 20-question test is filled out by the parent, and a follow-up portion is available for children who are classified as medium- to high-risk for autism spectrum disorder.
The Childhood Autism Spectrum Test, abbreviated as CAST and formerly titled the Childhood Asperger Syndrome Test, is a tool to screen for autism spectrum disorder in children aged 4–11 years, in a non-clinical setting. [1] It is also called the Social and Communication Development Questionnaire. [2]
There are many conditions comorbid to autism spectrum disorder, such as attention deficit hyperactivity disorder, anxiety disorders, and epilepsy. In medicine, comorbidity is the presence of one or more additional conditions co-occurring with the primary one, or the effect of such additional disorders.
MU Thompson Center research finds a generic blood pressure drug reduces anxiety in people with autism spectrum disorder.
He said many travelers with autism take a long time to feel comfortable in new environments, and exercises like the Breeze boarding demonstration are just one way they can get more familiar with ...
The Ritvo Autism & Asperger Diagnostic Scale (RAADS) is a psychological self-rating scale developed by Riva Ariella Ritvo (NPI UCLA and CSC Yale). An abridged and translated 14 question version was then developed at the Department of Clinical Neuroscience at the Karolinska Institute, to aid in the identification of patients who may have undiagnosed ASD.